AST's TxPharm COP and KPCOP welcome Drs. Taber, Anand, and Kadosh, and Ms. Flickinger to discuss the findings of an AST survey assessing transplant recipients’ perceptions of unmet immunosuppressant needs.
"Therapeutic needs in solid organ transplant recipients: The American Society of Transplantation patient survey"
(Am J Transplant. 2025 Dec;25(12):2565-2577. doi: 10.1016/j.ajt.2025.07.2474. Epub 2025 Jul 29.)
In this featured American Journal of Transplantation (AJT) article:
The American Society of Transplantation commissioned a survey assessing transplant recipients’ perceptions of unmet immunosuppressant needs. Topics included medication side effects, treatment burden, health-related quality of life, adherence, self-efficacy, costs, trust, and discrimination... Nearly all (92%) respondents reported at least 1 side effect (median of 3); most side effects occurred “often” or “always.” The majority (54%) of side effects were rated as having a “moderate” or “great deal” of impact on daily life... The findings demonstrated that side effects are nearly universally experienced and have a major burden on daily life. Immunosuppression induces a heavy toll on transplant recipients; there is an urgent need for new treatments to address these unmet needs. Read more.
Speaker:
David Taber, PharmD, MS, FAST • Medical University of South Carolina, Charleston, SC
Guest Speaker:
Madelyn "Maddie" Flickinger • AST Transplant Community Advisory Council (TCAC) Chair and Liver Transplant Recipient
Moderators:
This AST Journal Club Series webinar is hosted by the AST Transplant Pharmacy Community of Practice (TxPharm COP) and supported by the Kidney Pancreas Community of Practice (KPCOP). All AST Journal Clubs are free but registration is required to attend live.
To learn more about the American Journal of Transplantation (AJT), visit www.amjtransplant.org.